Achieve Life Sciences, Inc.
ACHV
$2.25
$0.073.21%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.76% | 46.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.21% | 47.86% | |||
| Operating Income | 2.21% | -47.86% | |||
| Income Before Tax | 1.21% | -47.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.21% | -47.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.21% | -47.88% | |||
| EBIT | 2.21% | -47.86% | |||
| EBITDA | 2.23% | -48.18% | |||
| EPS Basic | 1.67% | -47.75% | |||
| Normalized Basic EPS | 2.53% | -44.55% | |||
| EPS Diluted | 1.67% | -47.75% | |||
| Normalized Diluted EPS | 2.53% | -44.55% | |||
| Average Basic Shares Outstanding | 0.45% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
